o-Toluoyl Chloride CAS 933-88-0 Uruganda rwagati rwa Tolvaptan

Ibisobanuro bigufi:

Izina ryimiti: o-Toluoyl Chloride

URUBANZA: 933-88-0

Suzuma: ≥99.0%

Kugaragara: Amazi meza atagaragara

Hagati ya Tolvaptan (CAS 150683-30-0) yo kuvura Hyponatremia

Ubwiza buhanitse, Umusaruro wubucuruzi

Kubaza: alvin@ruifuchem.com


Ibisobanuro birambuye

Ibicuruzwa bifitanye isano

Ibiranga ibicuruzwa

Ibisobanuro:

Ibikoresho bya Shimi:

Izina ryimiti o-Toluoyl Chloride
Synonyme 2-Methylbenzoyl Chloride
Numero ya CAS 933-88-0
Inomero y'injangwe RF-PI396
Imiterere yimigabane Mububiko, Igipimo cyumusaruro kugeza kuri Toni
Inzira ya molekulari C8H7ClO
Uburemere bwa molekile 154.59
Ingingo yo gushonga 159.5-160.9 ℃
Ingingo yo guteka 88.0 ~ 90.0 ℃ / 12 mmHg (lit.)
Ubucucike 1.185 g / mL kuri 25 ℃ (lit.)
Ironderero n20 / D 1.5549 (lit.)
Amazi meza Igisubizo n'amazi
Ikirango Ruifu

Ibisobanuro:

Ingingo Ibisobanuro
Kugaragara Ibara ritagira ibara
Suzuma ≥99.0%
Benzoyl Chloride ≤0.30%
M & P-Methyl Benzoyl Chloride ≤0.50%
O-Toluic Acide ≤0.50%
Ibindi Bidasobanutse neza 20,20%
Impanuka zose ≤1.0%
Gutakaza Kuma ≤0.50%
Ikizamini Ibipimo ngenderwaho
Ikoreshwa Imiti ya farumasi

Amapaki & Ububiko:

Amapaki: Icupa, 25kg / Barrale cyangwa 180kg Ingoma ya plastike, cyangwa ukurikije ibyo umukiriya asabwa.

Imiterere yo kubika:Bika mu bikoresho bifunze ahantu hakonje kandi humye;Irinde urumuri nubushuhe.

Ibyiza:

1

Ibibazo:

Gusaba:

o-Toluoyl Chloride (CAS 933-88-0) ikoreshwa nka farumasi.o-Toluoyl Chloride ikoreshwa muri synthesis niba ibinini bya quinolinone nka SARS CoV 3CLpro inhibitor.Ikoreshwa kandi muri synthesis ya benzooxaboroles nkibikoresho byo mu kanwa birwanya inflammatory.o-Toluoyl Chloride ni intera ya Tolvaptan (CAS 150683-30-0) yo kuvura hyponatremia.Tolvaptan, izwi kandi ku izina rya OPC-41061, ni uburyo bwo guhitamo, guhatanira arginine vasopressin reseptor 2 antagonist ikoreshwa mu kuvura hyponatremia (urugero rwa sodium nkeya mu maraso) ifitanye isano no kunanirwa k'umutima, cirrhose, hamwe na syndrome ya hormone idakwiye (SIADH).Otsuka Pharmaceutical yemereye tolvaptan ku izina ryubucuruzi Samsca nyuma yuko FDA yemeye ibiyobyabwenge muri Gicurasi 2009.

  • Andika ubutumwa bwawe hano hanyuma utwohereze